Association of HLA-DQB1*0501 with scleroderma and its clinical features in chinese population

International Journal of Immunopathology and Pharmacology

Volumn 26, Issue 3, 2013, Pages 747-751

  Zhou, Xiaodong ^a   Yi, L ^a,b   Guo, X J ^a   Chen, E ^a   Zou, H J ^c,d   Jin, L ^e   Mayes, M D ^a   Assassi, S ^a   Wang, J C ^d,e  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b GANSU UNIVERSITY OF CHINESE MEDICINE   (China)

^c FUDAN UNIVERSITY   (China)

^d FUDAN UNIVERSITY   (China)

^e FUDAN UNIVERSITY   (China)

Author keywords

Chinese population; Genetic association; HLA; Scleroderma; Susceptibility

Indexed keywords

CENTROMERE ANTIBODY; HLA DQB1 ANTIGEN;

ALLELE; ARTICLE; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; ETHNIC GROUP; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCLERODERMA; AFRICAN AMERICAN; CAUCASIAN; ETHNICITY; GENE FREQUENCY; HAN CHINESE; HISPANIC;

ANTIBODIES, ANTINUCLEAR; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ BETA-CHAINS; HUMANS; MALE; ODDS RATIO; PHENOTYPE; PULMONARY FIBROSIS; RISK FACTORS; SCLERODERMA, SYSTEMIC;

EID: 84887481763     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201302600318     Document Type: Article

References (14)

1. Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007; 117:557-67. (Pubitemid 46348510)
2. Bunn CC, Black CM. Systemic sclerosis: an autoantibody mosaic. Clin Exp Immunol 1999; 117:207.
3. Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005; 35:35-42. (Pubitemid 41111469)
4. Arnett FC, Gourh P, Shete S, et al. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis 2010; 69:822-27.
5. Kang SH, Park MH, Song EY, Kang SJ, Lee EB, Song YW, Takeuchi F. Association of HLA class II genes with systemic sclerosis in Koreans. J Rheumatol 2001; 28:1577-83. (Pubitemid 32660631)
6. Tikly M, Rands A, McHugh N, Wordsworth P, Welsh K. Human leukocyte antigen class II associations with systemic sclerosis in South Africans. Tissue Antigens 2004; 63:487-90. (Pubitemid 38648217)
7. Simeón CP, Fonollosa V, Tolosa C, et al. Association of HLA class II genes with systemic sclerosis in Spanish patients. J Rheumatol 2009; 36:2733-36.
8. Kuwana M, Okano Y, Kaburaki J, Inoko H. HLA class II genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (scleroderma). Ann Rheum Dis 1995; 54:983-87.
9. Wang J, Assassi S, Guo G, et al. Clinical and serological features of systemic sclerosis in a Chinese cohort. Clin Rheumatol 2012; 32:617-21.
10. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581-90.
11. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15:202-5. (Pubitemid 18073738)
12. Akimoto S, Abe M, Ishikawa O. HLA-DRB1 and DQB1 genes in Japanese patients with systemic sclerosis. J Rheumatol 2000; 27:2940-42.
13. Trachtenberg E, Vinson M, Hayes E, et al. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China. Tissue Antigens 2007; 70:455-63. (Pubitemid 350075785)
14. Kuwana M, Kaburaki J, Okano Y, Inoko H, Tsuji K. The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma). J Clin Invest 1993; 92:1296-301. (Pubitemid 23273905)